PETQuant: Neurodegenerative Assessment in Clinical Research

webinar_thumbnail.pngDr. James Brewer, MD, PhD, Neurologist, UC San Diego, hosted a live webinar from our our San Diego headquarters entitled: PETQuant™: Neurodegenerative Dementia Assessment in Research. Dr. Brewer gave a fascinating and enlightening presentation about using PETQuant in clinical research and covered many topics in the video below, including:

  • Why patient native brain space is important in PET imaging
  • The value of quantifying brain structure volumes (via NeuroQuant®)
  • How PETQuant can simplify the process of interpreting PET scans
  • Several case studies

PETQuant is our recently launched for research only tool that provides brain segmentation using PET imaging studies to quantify subregional tracer binding in native brain space for FDG and Florbetapir.

If you would like more information about using PETQuant in your clinical research, please contact us.

Insights

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.
Scroll to Top